Hormonal & recovery

Ipamorelin

Growth-hormone releasing peptide
Ipamorelin research vial, 10 mg
Order here

Approved registered clients only.

PreviewIpamorelin Alpine Ascent data sheet preview

Data sheet

Ipamorelin

This preview is the one-page Alpine Ascent sheet for Ipamorelin. It is the reference copy for reconstitution, frequency, and the figures printed on the sheet. Open it when you want the full page.

What it is

Ipamorelin is a synthetic peptide classified as a growth-hormone secretagogue. It stimulates the body's natural production of growth hormone. Unlike other peptides in its class, it is highly selective, targeting specific receptors in the pituitary known as growth-hormone secretagogue receptors (GHS-R). It is studied for muscle growth, recovery, body composition, sleep, and overall wellness.

What researchers study it for

  • Muscle growth and performance
  • Improved body composition and fat metabolism
  • Recovery from exercise or injury
  • Healthy sleep patterns
  • Tissue repair and regenerative health
  • Anti-aging and overall wellness research

How it may work

  • Binds to growth-hormone secretagogue receptors (GHS-R) in the pituitary
  • Stimulates release of growth hormone into the bloodstream
  • Highly selective, with minimal effect on other hormones such as cortisol and prolactin
  • May support tissue repair, visceral fat metabolism, and fat metabolism
  • Studied for recovery, sleep, and overall wellness
  • Described on the sheet as a milder, more predictable profile than other GH-releasing agents

Research timeline

1–2 weeks

Early changes may include improved recovery and sleep quality.

3–6 weeks

Enhanced muscle recovery and body composition changes may become noticeable.

8–12 weeks

Continued improvements in strength, body composition, and overall well-being.

12+ weeks

Longer-term observations may include tissue repair, regenerative support, and sustained improvements in body composition.

10 mg research protocol

Reconstitution
1 mL bacteriostatic water
Final concentration
10 mg/mL
Starting dose
200–300 mcg
Syringe reference
5 units = 500 mcg. Read the data sheet for the unit mark that matches the starting dose.
Frequency
Daily
Route
Subcutaneous
Research duration
12 weeks on, 4 weeks off
Timing
In a fasted state. The sheet notes morning or before bed, and to avoid food around the dose.
Storage
Refrigerate after reconstitution

Research duration on the sheet: 12 weeks on and 4 weeks off, as listed on the sheet.

Reconstitution

  • 10 mg + 1 mL bacteriostatic water = 10 mg/mL.
  • 5 units = 500 mcg.

Titration notes

  • No dose-escalation schedule is specified on the source protocol.
  • Starting dose on the sheet: 200–300 mcg. Adjustments are described as individual to the research design.

Important considerations

  • For research use only. Not for human use.
  • Use in a fasted state, depending on the research design.
  • If the dose is missed, the sheet says not to double it. Resume at the next scheduled time.
  • Not recommended during pregnancy or breastfeeding.
  • Store appropriately after reconstitution.

Evidence summary

Human research
Emerging
Performance research
Moderate
Metabolic research
Moderate
Recovery and injury research
Limited
Long-term safety data
Limited

References

Completed published studies are listed below and labeled as in vitro, animal, or human research. Favorable and unfavorable results are both included, including cancer studies. This is not every paper on the compound, and it is not a recommendation or a dose.

The completed reports with a clear signal are animal studies. A completed cancer study was not identified.

Available strength

10 mg vial. Format: Lyophilized powder.

For educational and research purposes only. These materials are not approved to diagnose, treat, cure, or prevent any disease. Nothing on this page is a dose recommendation or medical advice. The Alpine Ascent data sheet is the reference copy for each compound.